SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following the release of positive Week 52 Phase 3 trial results, which investors are positioning as a strong best-in-class indicator for their skin drug, sonelokimab. The community is actively debating the potential for an upcoming acquisition and monitoring institutional accumulation, while some retail traders express frustration over recent price volatility and the timeline for further clinical data readouts.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure Corp is trending as investors bet on the company's pivot from crypto mining to high-demand AI and HPC data center infrastructure, fueled by recent FERC grid connectivity mandates and anticipation of upcoming lease contracts. The community is actively discussing the stock's upward momentum, potential Russell 3000 index inclusion, and the impact of institutional positioning on future price action.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is attracting intense community interest as high trading volume and recent insider activity fuel speculation about potential acquisition interest or upcoming strategic catalysts. Investors are actively discussing the impact of new management's positioning, while closely watching key technical levels and patent developments that could signal a breakout for the stock.

HIVE Digital Technologies Ltd. engages in building a bridge between the digital currency and blockchain sector and traditional capital markets. The firm operates data centers for computing and mining cryptocurrencies, including Bitcoin and other coins. It owns and operates green energy-powered data center facilities in Canada, Sweden, and Iceland. The company was founded on June 24, 1987 and is headquartered in San Antonio, TX.

HIVE Digital Technologies Ltd.

HIVE Digital Technologies Ltd

HIVE Digital Technologies is generating significant investor interest following the validation of its Paraguay AI infrastructure by a Columbia University study and ongoing discussions regarding its strategic expansion into sovereign AI data centers. The community is actively debating the stock's valuation as it pivots from traditional mining to high-performance computing, with many users focusing on the long-term potential of its upcoming data center projects in Canada and Sweden.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending due to its aggressive price appreciation fueled by a persistent global memory shortage and robust demand from AI data centers, leaving the community divided between those riding the momentum and others fearing a bubble-driven correction. Investors are intensely focused on memory sector health, with many closely watching upcoming earnings catalysts for signs of continued sector strength or a potential trend reversal.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is experiencing a significant surge and high investor interest following the announcement of positive Phase 3 topline results for its DT120 treatment in major depressive disorder. The community is actively debating the company's valuation and long-term potential, with bulls citing robust clinical data and upcoming catalysts, while skeptics focus on concerns regarding cash burn, potential share dilution, and the competitive landscape for psychedelic therapies.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is seeing heavy volume and a significant rebound as investors pivot focus from recent dilution concerns toward strong AI infrastructure demand, including a new blueprint for Nvidia's Vera Rubin systems. The stock remains a battleground as the community debates whether the influx of institutional buying signals a long-term bottom or continues to face volatility from retail skepticism.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital is surging as investors speculate on potential hyperscaler lease agreements and the company's upcoming inclusion in the Russell 3000 index. The community is heavily focused on the company's 'Behind-the-Meter' energy strategy for data centers, viewing it as a major catalyst for a significant valuation re-rate.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is trending as investors debate the company's aggressive pivot toward AI and high-performance computing infrastructure, with the community actively speculating on the timing of potential hyperscaler tenant agreements. While sentiment remains sharply divided between those betting on long-term institutional value and those frustrated by recent price volatility and management's leadership, trading volume remains elevated as participants react to broader sector shifts and Bitcoin's influence on mining profitability.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing significant selling pressure and heightened volatility, as investors weigh concerns over subscriber growth against management's capital allocation and potential M&A activity. The community remains deeply polarized, with bears aggressively betting on further downside following recent technical breaks, while bulls are scouting for value in what they consider an oversold market leader.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$INKT one just needed to listen to the call last quarter. Hammond was so eloquent and full of passion, very different from the usual. It was obvious something big was going on. I tripled my position after that.
Always listen to calls, transcripts don&#39;t convey the nuances

Alberto Diaz

David

StockTwits For Android 

MiNK Therapeutics Inc

 one just needed to listen to the call last quarter. Hammond was so eloquent and full of passion, very different from the usual. It was obvious something big was going on. I tripled my position after that.
Always listen to calls, transcripts don't convey the nuances

Spartrap

@Spartrap Maybe Hammond is taking belly-dancing lessons

StockTwits Web

 Maybe Hammond is taking belly-dancing lessons

Stephen

@OrientBeach lol. I think the passion is genuine. You have to remember she is the Uber-specialist of ards. Reading back the Nature article she co-authored on the COVID era trial of agent-797 in ards was quite an eye-opener to the great potential of the treatment. The excitement is understandable 

https://www.nature.com/articles/s41467-024-44905-z

Invariant natural killer T (iNKT) cells recognize abnormal cells, but their T cell receptor is not variable and kill cancerous or infected target cells without MHC I restriction. Here, the authors show that in a clinical trial, donor-unrestricted allogeneic iNKT cells could be safely administered to human COVID-19 patients suffering from acute respiratory distress syndrome and trigger an anti-inflammatory response.

Nature

A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome - Nature Communications

 lol. I think the passion is genuine. You have to remember she is the Uber-specialist of ards. Reading back the Nature article she co-authored on the COVID era trial of agent-797 in ards was quite an eye-opener to the great potential of the treatment. The excitement is understandable 



@Spartrap I didn’t know Dr. Hammond was held n such high regards on ARDS … thats  really encouraging

 I didn’t know Dr. Hammond was held n such high regards on ARDS … thats  really encouraging